Maze Therapeutics exchanges 2,776,007 common shares for pre-funded warrants
MAZE•Maze Therapeutics exchanged 2,776,007 common shares held by Frazier Life Sciences funds for pre-funded warrants on October 15, 2026. The warrants cover the same number of shares at an exercise price of $0.001 per share; outstanding common shares totaled 53,931,889 on October 16.
1. Share exchange terms
Maze Therapeutics exchanged 2,776,007 common shares held by Frazier Life Sciences funds for pre-funded warrants on October 15, 2026. The warrants cover 2,776,007 common shares at an exercise price of $0.001 per share and may be exercised immediately, subject to a 9.99% beneficial-ownership limit and certain exceptions. Outstanding common shares totaled 53,931,889 as of October 16.
